Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
McKinsey
Mallinckrodt
Medtronic
Boehringer Ingelheim

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR TEMOZOLOMIDE

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Temozolomide

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00003062 Temozolomide in Patients With Progressive or Recurrent Non-small Cell Lung Cancer Completed European Organisation for Research and Treatment of Cancer - EORTC Phase 2 1997-07-01 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effect of temozolomide in patients with progressive or recurrent stage IV non-small cell lung cancer, with or without brain metastases, who have not been treated for metastatic disease with chemotherapy.
NCT00003176 Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma Unknown status National Cancer Institute (NCI) Phase 2 1998-01-01 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of temozolomide and carmustine in treating patients with anaplastic glioma.
NCT00003176 Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma Unknown status North American Brain Tumor Consortium Phase 2 1998-01-01 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of temozolomide and carmustine in treating patients with anaplastic glioma.
NCT00003273 Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor Withdrawn New York University School of Medicine Phase 2 1997-11-01 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of different regimens of combination chemotherapy followed by peripheral stem cell transplantation in treating children who have newly diagnosed brain tumor.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Temozolomide

Condition Name

Condition Name for Temozolomide
Intervention Trials
Glioblastoma 151
Glioblastoma Multiforme 104
Brain and Central Nervous System Tumors 89
Gliosarcoma 42
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Temozolomide
Intervention Trials
Glioblastoma 355
Glioma 162
Central Nervous System Neoplasms 109
Nervous System Neoplasms 107
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Temozolomide

Trials by Country

Trials by Country for Temozolomide
Location Trials
Canada 224
Australia 99
United Kingdom 86
France 79
Spain 66
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Temozolomide
Location Trials
California 155
Texas 131
New York 127
North Carolina 123
Pennsylvania 119
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Temozolomide

Clinical Trial Phase

Clinical Trial Phase for Temozolomide
Clinical Trial Phase Trials
Phase 4 3
Phase 3 59
Phase 2/Phase 3 10
[disabled in preview] 375
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Temozolomide
Clinical Trial Phase Trials
Completed 279
Recruiting 158
Active, not recruiting 108
[disabled in preview] 104
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Temozolomide

Sponsor Name

Sponsor Name for Temozolomide
Sponsor Trials
National Cancer Institute (NCI) 199
Schering-Plough 36
M.D. Anderson Cancer Center 31
[disabled in preview] 31
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Temozolomide
Sponsor Trials
Other 856
Industry 355
NIH 209
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
Medtronic
Express Scripts
Boehringer Ingelheim
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.